1. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996;71:576–86.
2. Goodridge GM, Shorvon SD. Epileptic seizures in a population of 6000. Br Med J. 1983;287:645–7.
3. The Social Committee of Korean Epilepsy Society.. Driving in patients with epilepsy: doctor’s perspective. J Korean Epilepsy Soc. 2010;14:1–5.
4. Inoue Y, Ito M, Kurihara M, Morimoto K; Commission on Legal Affairs, Japan Epilepsy Society (Japan chapter of ILAE). Epilepsy and driving in Japan. Epilepsia. 2004;45:1630–5.
5. An advisory board to the Driving Licence Committee of the European Union. Epilepsy and driving in Europe: a report of the Second European Working Group on Epilepsy and Driving. 3. April. 2005;
6. Krauss GL, Ampaw L, Krumholz A. Individual state driving restrictions for people with epilepsy in the US. Neurology. 2001;57:1780–5.
7. Sheth SG, Krauss G, Krumholz A, Li G. Mortality in epilepsy: driving fatalities vs. other causes of death in patients with epilepsy. Neurology. 2004;63:1002–7.
8. Belgian Traffic Data. 2001. http://www.statbel.fgov.be/figures/d37_nl.asp.
9. American Academy of Neurology, American Epilepsy Society and Epilepsy Society. Consensus statement, statutory provisions and model regulations regarding driver licensing and epilepsy. Epilepsia. 1994;35:696–705.
11. Thomas RH, King WH, Johnston JA. Awake seizures after pure sleep-related epilepsy: a systemic review and implications for driving law. J Neurol Neurosurg Psychiatry. 2010;81:130–5.
12. D’Alessandro R, Guarino M, Greco G, et al. Risk of seizures while awake in pure sleep epilepsies: a prospective study. Neurology. 2004;62:254–7.
13. Elwes R, Chesterman P, Reynolds EH. Prognosis after first tonic-clonic seizure. Lancet. 1985;2:752–3.
15. First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology. 1993;43:478–83.
16. Camfield P, Camfield C, Dooley J, Smith E, Garner B. A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhood. Neurology. 1989;39:851–2.
17. Berg A, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991;41:965–72.
18. Beghi E, Berg A, Hauser A. Treatment of single seizures. Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers; 1997.
19. Hart YM, Sander JW, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet. 1990;336:1271–4.
20. Shinnar S, Berg AT, O’Dell C, Newstein D, Moshe SL, Hauser WA. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol. 2000;48:140–7.
21. Hui AC, Tang A, Wong KS, Mok V, Kay R. Recurrence After a First Untreated Seizure in the Hong Kong Chinese Population. Epilepsia. 2001;42:94–7.
22. Annegers JF, Shirts SB, Hauser WA, Kurland LT. Risk of recurrence after an initial unprovoked seizure. Epilepsia. 1986;27:43–50.
23. Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998;338:429–34.
24. Report of the Quality Standards Subcommitte of the American Academy of Neurology Practice Parameter. A guideline for discontinuing antiepileptic drugs in seizure-free patients-Summary statement. Neurology. 1996;47:600–2.
26. Sonnen AE; the European Working Group. Epilepsy and Driving Proceedings First European Workshop epilepsy and Driving Licences Group 1. IBE. May. 1995;
27. American Academy of Neurology position statement on physician reporting on medical conditions that may affect driving competence. Neurology. 2007;68:1174–7.